Circulating Tumor Markers of the New Millennium: Target Therapy, Early Detection, and Prognosis - CLEARANCE ITEM

Price: $11.99
In Stock: 1
Catalog No.: B60002-CL
Publisher/Vendor: American Association for Clinical Chemistry (AACC)
Author: James T. Wu
Pages: 173
Format: Softcover Book
 
Circulating Tumor Markers of the New Millennium: Target Therapy, Early Detection, and Prognosis

Original description from the release of this title:

Circulating Tumor Markers of the New Millennium introduces new tumor markers, including cytokines, growth factors, oncoproteins, and mutated suppressor proteins involved in the signal transduction pathway, the cell cycle, and apoptosis. The book also reviews other new tumor markers - angiogenic factors, adhesion molecules, and molecules that are associated with certain types and properties of tumor cells - and describes ELISAs developed for most of them. These new tumor markers differ from currently used tumor markers in that they have the potential for target identification to facilitate more effective target therapy. They might also be used to detect tumors at early or benign stages and to predict prognosis, assisting in the design of therapeutic strategy. This book was written to introduce investigators to the new tumor markers and to encourage investigators to further investigate the clinical applications of these markers.